The price of Oculus Innovative Sciences, Inc. (Nasdaq:OCLS) stock soared $0.65 (or +20.63%) to $3.80, after the company reported a regulatory approval in Mexico for its new Microcyn60(R) Oral Care family of products for the treatment in both mouth and throat infections. Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) shares after opening at $5.31 moved to $5.99 on last trade day and at the end of the day closed at $5.84. Company price to sales ratio in past twelve months was calculated as 2.82 and price to cash ratio as 11.70. Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) showed a positive weekly performance of 49.74%.
GTx (NASDAQ:GTXI) posted its quarterly earnings results on Tuesday. The company reported ($0.12) earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.13) by $0.01, Analyst Ratings Net reports. GTx, Inc. (NASDAQ:GTXI) shares advanced 8.79% in last trading session and ended the day on $1.98. GTXI return on equity ratio is recorded as -190.30% and its return on assets is -144.80%. GTx, Inc. (NASDAQ:GTXI) yearly performance is -55.51%.
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL), a clinical stage drug development company is making the right moves. The recent financial performance of the company as well as results from ongoing clinical trials has attracted both investors as well as analysts. Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) shares moved up 5.62% in last trading session and was closed at $4.70 while trading in range of $4.40 – $4.80 – Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) year to date (YTD) performance is 64.91%.
Coronado Biosciences, Inc. (NASDAQ:CNDO) announced its financial results for the fourth quarter and year ended December 31, 2013. Coronado Biosciences Inc (NASDAQ:CNDO) weekly performance is -21.32%. On last trading day company shares ended up $2.03. Coronado Biosciences Inc (NASDAQ:CNDO) distance from 50-day simple moving average (SMA50) is -24.86%. Analysts mean target price for the company is $1.90.